Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large intestine motility and gut physiology refer to the coordinated muscular and secretory activities of the colon that facilitate the processing and elimination of waste. This system is governed by the enteric nervous system (ENS), which integrates signals from the central nervous system and local mechanical or chemical stimuli to regulate peristalsis and fluid transport, as described by StatPearls [1] and the NIH [5]. Disruptions in these physiological processes lead to common clinical conditions such as chronic idiopathic constipation (CIC), irritable bowel syndrome (IBS), and opioid-induced constipation (OIC), according to the Mayo Clinic [2]. While Large intestine motility and gut physiology is a broad physiological category rather than a single molecular target, it is the therapeutic focus for drugs like prucalopride (a 5-HT4 agonist) and linaclotide (a GC-C agonist), which aim to restore normal function by acting on specific receptors within the gut wall [3][4]. These interventions aim to normalize transit time and improve stool consistency by modulating muscle contraction and epithelial secretion.
Pharmacological agents modulate this system by targeting specific receptors and channels, such as 5-HT4 receptors to stimulate motility, guanylate cyclase-C (GC-C) to increase fluid secretion, or mu-opioid receptors to inhibit or restore transit [1][3][4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large intestine motility and gut physiology.